Elsevier

Ophthalmology

Volume 111, Issue 8, August 2004, Pages 1539-1545
Ophthalmology

Original article
The giant fornix syndrome: An unrecognized cause of chronic, relapsing, grossly purulent conjunctivitis

https://doi.org/10.1016/j.ophtha.2004.01.037Get rights and content

Abstract

Aim

To describe a group of elderly patients presenting with chronic, relapsing, copiously purulent conjunctivitis, in which the condition was often perpetuated by the sequestration of a large number of bacteria on a protein coagulum lodged in the recesses of a large upper conjunctival fornix.

Patients and methods

Retrospective review of a noncomparative case series, drawn from patients attending the lacrimal clinic at Moorfields Eye Hospital.

Outcome measures

Characterization of this unrecognized syndrome and its response to treatment.

Results

Twelve patients (10 female) presented between the ages of 77 and 93 years (mean, 85; median, 86) with a history of chronic relapsing bacterial conjunctivitis affecting, with 2 exceptions, just one eye. All had experienced multiple episodes of markedly purulent conjunctivitis and chronic ocular discharge for between 8 and 48 months (mean, 23.5; median, 24) before referral, and the patients had received multiple courses of treatment. Three had successful external dacryocystorhinostomy (for nasolacrimal duct occlusion) before the final diagnosis of giant fornix syndrome was made, 9 had developed corneal vascularization and scarring before referral, and 5 had suffered prior spontaneous corneal perforation or thinning. All patients had deep upper conjunctival fornices in association with the changes of age-related dehiscence of the levator muscle aponeurosis. Copious amounts of thick, purulent debris and a yellow coagulum were lodged in the depths of the upper fornix—this debris universally culturing Staphylococcus aureus. The condition settled rapidly on appropriate systemic antibiotics (ciprofloxacin or ofloxacin), intensive topical antibiotics, and high-dose, high-potency steroids; some patients required repeated treatment or needed to continue the use of a single drop of a combined steroid–antibiotic to prevent relapse.

Conclusion

The capacious upper fornix of the elderly may harbor a coagulum colonized by S. aureus, leading to chronic conjunctivitis that may lead to severe sight impairment due to toxic keratopathy and secondary corneal vascularization.

Section snippets

Patients and methods

The clinical notes for patients referred, between 1991 and 2002, with recurrent episodes of gross purulent conjunctivitis and characterized by extremely severe inflammation of a large upper conjunctival fornix were reviewed retrospectively. Ethical committee approval was not required for this study.

Case 1

A frail 91-year-old woman presented with a 2-year history of recurrent episodes of left conjunctivitis, with copious amounts of creamy ocular discharge that gummed the eye closed. She had received multiple courses of topical antibiotic therapy and, 1 year before referral, had developed a spontaneous (nontraumatic) corneal perforation that healed on medical therapy.

The patient had hand movements vision in the affected eye at time of referral to Moorfields Eye Hospital, due to a central scar at

Discussion

These patients all presented with chronic, severe, copiously purulent pseudomembranous conjunctivitis with, in many cases, a serious disturbance of the ocular surface and corneal scarring secondary to the toxic environment. The corneal changes were variable: all patients displayed a severe punctate epithelial keratopathy, reversible in some cases (e.g., nos. 3 and 11) (Fig 1E) but leading to persistent dystrophic epithelium in others (nos. 7 and 9). Prolonged disease was associated with

Acknowledgements

The author thanks his colleagues, Mr John Dart and Mr Frank Larkin, for allowing him to report cases under his and their joint care at Moorfields Eye Hospital.

References (5)

There are more references available in the full text version of this article.

Cited by (0)

Manuscript no. 230326.

The author has no conflict of interest or financial interest in the subject presented.

View full text